131 related articles for article (PubMed ID: 12586214)
1. Preventive effect of zelandopam, a dopamine D1 receptor agonist, on cisplatin-induced acute renal failure in rats.
Yatsu T; Aoki M; Inagaki O
Eur J Pharmacol; 2003 Feb; 461(2-3):191-5. PubMed ID: 12586214
[TBL] [Abstract][Full Text] [Related]
2. Effect of zelandopam, a dopamine D1-like receptor agonist, in puromycin aminonucleoside nephrosis rats.
Yatsu T; Aoki M; Tanaka A
Eur J Pharmacol; 2005 Mar; 510(1-2):121-6. PubMed ID: 15740732
[TBL] [Abstract][Full Text] [Related]
3. Renal effect of YM435, a new dopamine D1 receptor agonist, in anesthetized dogs.
Yatsu T; Arai Y; Takizawa K; Kasai-Nakagawa C; Takanashi M; Uchida W; Inagaki O; Tanaka A; Asano M; Honda K; Takenaka T
Eur J Pharmacol; 1997 Mar; 322(1):45-53. PubMed ID: 9088869
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of relaxin against cisplatin-induced nephrotoxicity in rats.
Yoshida T; Kumagai H; Kohsaka T; Ikegaya N
Nephron Exp Nephrol; 2014; 128(1-2):9-20. PubMed ID: 25403022
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of uranyl nitrate and cisplatin-induced renal failure in rat.
Mahmood I; Waters DH
Eur J Drug Metab Pharmacokinet; 1994; 19(4):327-36. PubMed ID: 7737234
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological and pharmacokinetic characteristics of YM435, a novel dopamine DA1-receptor agonist, in anaesthetized dogs.
Yatsu T; Miyamoto I; Kaneko-Takanuki F; Watanabe T; Takenaka T
J Pharm Pharmacol; 1997 Sep; 49(9):892-6. PubMed ID: 9306257
[TBL] [Abstract][Full Text] [Related]
7. Febuxostat exerts dose-dependent renoprotection in rats with cisplatin-induced acute renal injury.
Fahmi AN; Shehatou GS; Shebl AM; Salem HA
Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):819-30. PubMed ID: 27215580
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of KW-3902, an adenosine A1-receptor antagonist, against cisplatin-induced acute renal failure in rats.
Nagashima K; Kusaka H; Karasawa A
Jpn J Pharmacol; 1995 Apr; 67(4):349-57. PubMed ID: 7650867
[TBL] [Abstract][Full Text] [Related]
9. Effect of YM435, a dopamine DA1 receptor agonist, in a canine model of ischemic acute renal failure.
Yatsu T; Arai Y; Takizawa K; Kasai-Nakagawa C; Takanashi M; Uchida W; Inagaki O; Tanaka A; Takenaka T
Gen Pharmacol; 1998 Nov; 31(5):803-7. PubMed ID: 9809482
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of cisplatin-induced acute renal failure with 8-cyclopentyl-1,3-dipropylxanthine.
Knight RJ; Collis MG; Yates MS; Bowmer CJ
Br J Pharmacol; 1991 Dec; 104(4):1062-8. PubMed ID: 1810593
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic characterization of YM435, a novel dopamine DA1 receptor agonist, in anesthetized dogs.
Yatsu T; Takizawa K; Kasai-Nakagawa C; Uchida W; Tanaka A; Asano M; Honda K; Takenaka T
J Cardiovasc Pharmacol; 1997 Mar; 29(3):382-8. PubMed ID: 9125677
[TBL] [Abstract][Full Text] [Related]
12. The role of oxygen free radicals in cisplatin-induced acute renal failure in rats.
Matsushima H; Yonemura K; Ohishi K; Hishida A
J Lab Clin Med; 1998 Jun; 131(6):518-26. PubMed ID: 9626987
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin attenuates experimental contrast-induced acute kidney injury: a role for TLR4/MyD88 signaling pathway.
Yue R; Zuo C; Zeng J; Su B; Tao Y; Huang S; Zeng R
Ren Fail; 2017 Nov; 39(1):643-651. PubMed ID: 28805489
[TBL] [Abstract][Full Text] [Related]
14. Ameliorative effect of flunarizine in cisplatin-induced acute renal failure via mitochondrial permeability transition pore inactivation in rats.
Muthuraman A; Sood S; Singla SK; Rana A; Singh A; Singh A; Singh J
Naunyn Schmiedebergs Arch Pharmacol; 2011 Jan; 383(1):57-64. PubMed ID: 21058009
[TBL] [Abstract][Full Text] [Related]
15. Acute renal failure following intraperitoneal injection of cis-diamminedichloroplatinum.
Hosokawa S; Kohira S; Tomotoshi T
Urol Int; 1984; 39(4):246-9. PubMed ID: 6541388
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity.
Baliga R; Zhang Z; Baliga M; Ueda N; Shah SV
Kidney Int; 1998 Feb; 53(2):394-401. PubMed ID: 9461098
[TBL] [Abstract][Full Text] [Related]
17. Hydroxyl radical scavenger ameliorates cisplatin-induced nephrotoxicity by preventing oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria.
Santos NA; Bezerra CS; Martins NM; Curti C; Bianchi ML; Santos AC
Cancer Chemother Pharmacol; 2008 Jan; 61(1):145-55. PubMed ID: 17396264
[TBL] [Abstract][Full Text] [Related]
18. Selective ET(A) receptor blockade protects against cisplatin-induced acute renal failure in male rats.
Helmy MM; Helmy MW; Abd Allah DM; Abo Zaid AM; Mohy El-Din MM
Eur J Pharmacol; 2014 May; 730():133-9. PubMed ID: 24632086
[TBL] [Abstract][Full Text] [Related]
19. Post-treatment effects of erythropoietin and nordihydroguaiaretic acid on recovery from cisplatin-induced acute renal failure in the rat.
Lee DW; Kwak IS; Lee SB; Song SH; Seong EY; Yang BY; Lee MY; Sol MY
J Korean Med Sci; 2009 Jan; 24 Suppl(Suppl 1):S170-5. PubMed ID: 19194548
[TBL] [Abstract][Full Text] [Related]
20. Red ginseng ameliorates acute cisplatin-induced nephropathy.
Kim YJ; Lee MY; Son HY; Park BK; Ryu SY; Jung JY
Planta Med; 2014 Jun; 80(8-9):645-54. PubMed ID: 24963615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
